Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...
To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Background The global surge in ultra-processed food (UPF) consumption is a major public health challenge, particularly among ...
BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB0) (OTCQB: BVAXF) ("BioVaxys" or the "Company"), a clinical stage biotechnology company focused on developing advanced treatments in oncology, infectious ...